FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list
This problem is remedied by using a Methyl B12 supplement
To report SUSPECTED ADVERSE EVENTS, contact Actavis at 1-800-272-5525 or FDA at 1-800-FDA-1088 or for voluntary reporting of adverse reactions
International journal of immunopathology and pharmacology
Using the peptide calculator , enter the actual water volume you added, and it gives you the corrected dose in units
If your serum has changed colour, developed sediment, or exceeded its stability window, discard it